This correlation is validated by the Kaplan–Meier survival curve (Figure 4), illustrating that patients with higher COL11A1 levels experience increased instances of metastasis, recurrence, or death compared to those with lower COL11A1 expression in the primary tumor. Here, COL11A1 is linked to neoplasm.